WO2000066205A1 - An inhaler - Google Patents

An inhaler Download PDF

Info

Publication number
WO2000066205A1
WO2000066205A1 PCT/SG1999/000051 SG9900051W WO0066205A1 WO 2000066205 A1 WO2000066205 A1 WO 2000066205A1 SG 9900051 W SG9900051 W SG 9900051W WO 0066205 A1 WO0066205 A1 WO 0066205A1
Authority
WO
WIPO (PCT)
Prior art keywords
cartridge
applicator
inhalant
nozzle
inhaler
Prior art date
Application number
PCT/SG1999/000051
Other languages
French (fr)
Inventor
Mui Lick Kow
Original Assignee
Haw Par Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haw Par Healthcare Ltd filed Critical Haw Par Healthcare Ltd
Priority to PCT/SG1999/000051 priority Critical patent/WO2000066205A1/en
Priority to CN99816584.0A priority patent/CN1367708A/en
Priority to TW088114168A priority patent/TW442305B/en
Publication of WO2000066205A1 publication Critical patent/WO2000066205A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/08Inhaling devices inserted into the nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/0021Mouthpieces therefor
    • A61M15/0025Mouthpieces therefor with caps

Definitions

  • the present invention relates to an inhaler for inhaling and applying medicinal substances and the like.
  • Inhalers are used for the relief of nasal congestion or simply for refreshing inhalation.
  • Medicated formulas are generally used as the inhaling substance, or inhalant, and primarily contain methanol and essential oils .
  • a wick saturated with the inhalant is permanently enclosed within a dome-ended inhaler housing, or nozzle, and a variant of the inhaler is to mount the nozzle on a cartridge that is functionally separate from the nozzle.
  • the cartridge serves only as a container to hold the inhalant .
  • the present invention is intended to provide a means of directly applying the inhalant in a controlled manner and prolong the useful life of the inhaler. ⁇ ⁇ Further, the medication can be dabbed on or applied directly to give a stronger effect than through inhalation from the ozzle. This provides a convenient three-in-one application from a single device.
  • an inhaler including: a cartridge for storing inhalant, the cartridge having an opening to dispense the inhalant; an applicator detachably connected to the cartridge, the applicator including inhalant retention means ; and a nozzle detachably connected to the applicator; whereby removal of the nozzle from the applicator exposes the retention means which provides accessibility to saturate the retention means with inhalant from the cartridge and allows direct application of inhalant with the applicator, and wherein inhalant from the retention means can be inhaled through the nozzle when the nozzle is connected to the applicator.
  • the applicator can freely rotate on the cartridge to easily and correctly align the cartridge and applicator during manufacturing.
  • the retention means is preferably a sponge and more preferably, a sponge of cosmetic or medical grade.
  • the applicator is preferably attached to the cartridge at the opening.
  • the opening in the cartridge is sealed prior to first use and is unsealed by means of a piercing spike on the applicator.
  • the piercing spike also functions as a plug -for the opening once it is unsealed. ⁇ " ⁇
  • an O-ring be disposed between the cartridge and applicator to separate the cartridge and applicator to prevent inadvertent piercing of the sealed opening.
  • the nozzle is provided with apertures through which the inhalant is inhaled.
  • Figure 1 is a perspective view of a preferred embodiment of the invention
  • Figure 2(a) is a sectional view along line A-A in figure 1 of a first arrangement of the invention illustrating the cartridge;
  • Figure 2(b) is a sectional view along ling A-A in figure 1 of a second arrangement of the invention illustrating the applicator in connection with the cartridge;
  • Figure 2(c) is a sectional view along line A-A in figure 1 of a third arrangement of the invention illustrating the nozzle in connection with the applicator and cartridge;
  • Figure 3 is an exploded perspective view of the preferred embodiment of the invention.
  • the inhaler 10 of the present invention in its preferred embodiment is illustrated in figures 1 and 3 and includes a cylindrical cartridge 11 forming the base of the inhaler.
  • the cartridge stores the inhaling substance, that is, the inhalant, which dispenses from the cartridge out of a regulated drip opening 12 located centrally at one end of the cartridge 11.
  • An applicator 13 is screwed to the end of the cartridge having the opening and includes retention means 14 to retain inhalant .
  • the inhalant retention means is a sponge.
  • the applicator can be used to directly apply inhalant to a surface in smaller and less concentrated quantities than direct application from the cartridge.
  • a nozzle 15 is disposed over the sponge and detachably connects with the applicator.
  • the applicator is also the source of inhalant vapours, that is, vapours from the sponge are inhaled through the nozzle.
  • a cap 17 is adapted to cover the nozzle and provides the inhaler with a compact appearance.
  • the entire inhaler, with the exception of the sponge, is made of plastics.
  • Figure 2(a) illustrates a first user arrangement of the inhaler wherein the cartridge 11 containing inhalant can be used for direct concentrated application of the inhalant.
  • the end wall 20 of the cylindrical cartridge in which the central opening 12 is formed is made of a softer plastic than the rest of the cartridge.
  • the central opening in the soft plastic end wall is sealed with a thin piercable layer 21 of the soft plastic.
  • the plastic seal is punctured with a piercing spike 29 located on the underside of the applicator 13.
  • Figure 2(b) illustrates a second user arrangement wherein the applicator is used to directly apply inhalant by dabbing the inhalant saturated sponge on to a surface .
  • the concentration of the inhalant applied with the applicator is less than application with the cartridge.
  • the applicator 13 is screw fitted onto the cartridge at the end which has the opening 12.
  • An external thread 22 at this end of the cartridge engages with an internal thread 23 on an annular skirt 2*4 of the applicator 13.
  • At the other end of the annular skirt is a stepped section 25 defining an annular shoulder 26 and a reduced annular section 27 in coaxial alignment with the annular skirt 24.
  • the upper end of the annular skirt is closed by the reduced annular section 27.
  • the piercing spike 29 depends centrally from the reduced section 27 and points towards the central opening 12.
  • Above the annular reduced section 27 is an upright hollow rectangular sponge holder 30 with an upper opening 31 in which to insert a sponge 14. Longitudinal ridges 32 along the interior walls of the sponge holder ensure the inserted sponge is gripped in place.
  • the sponge preferably has a high liquid retention.
  • the annular skirt, spike, reduced annular section and sponge holder are moulded as a single component.
  • the spike 29 moves downwardly towards the sealed opening as the applicator is screwed onto the cartridge.
  • the length of the spike is such that when the applicator is fully screwed onto the cartridge the spike pierces the sealed layer and protrudes into the opening.
  • inhalant can be dispensed from the cartridge through the opening and directly applied to tissues, skin or the like.
  • the inhalant is directly applied to and saturates the sponge on the applicator.
  • the applicator is first unscrewed and separated from the cartridge. Inhalant is dispensed from the cartridge by lightly tapping the cartridge. Since the whole upper part of the sponge is exposed and accessible, it is easy to saturate the sponge with inhalant .
  • the upper part of the sponge is the most important in terms of close proximity to the nasal region during inhalation.
  • the present inhaler ensures the upper part is fully saturated so as to deliver strong and effective vapours. Consequently, the inhaler has a longer useful life than conventional inhalers.
  • an O-ring 35 is disposed between the applicator 13 and cartridge 11. The O-ring rests on a seat
  • Figure 2(c) illustrates a third user arrangement wherein the nozzle 15 is fitted over the applicator 13 to provide a comfortable means for inhaling inhalant vapours .
  • the nozzle has an annular flange 40 which forms a press fit with the annular shoulder 26 on the applicator 13. Projecting upwardly from the annual flange is a hollow cylindrical portion 41. The top end of the hollow portion 41 smoothly curves inwardly to partly close the upper end thereof but leaving a central circular aperture 16. Other circular apertures 16, in this embodiment four, are provided circumferentially on the wall of the hollow portion 41.
  • the sponge 14 and sponge holder 30 of the applicator extend upwardly into the hollow portion so that the nozzle encloses the sponge.
  • the apertures 16 on the nozzle 15 allow vapour from the saturated sponge to be ⁇ inhaled through the nozzle.
  • the inhaler cap is simply a cylindrical wall closed at the non-threaded upper end.
  • the inhaler has three separate arrangements for administering the inhalant. Beginning with the full assembly as illustrated in figures 1 and 3, the cap is unscrewed and removed so the inhaler can be used as a regular nasal inhaler. The nozzle is further removed (for ease the nozzle is kept in engagement with the cap) exposing the saturated sponge which can be dabbed onto skin, etc and easily re-saturated. Lastly, the applicator is unscrewed from the cartridge (for ease the applicator is attached to the nozzle and cap assembly) thus exposing the regulated opening of the cartridge which can be used to directly dispense inhalant by lightly tapping the cartridge. The concentration of inhalant delivered from the cartridge is considerably higher than the inhalant applied with the applicator sponge.
  • the sponge is pre-soaked at the point of manufacture to ensure that vapour is available for inhalation upon first use.
  • the sponge is kept saturated by repeatedly priming the sponge by dispensing inhalant from the cartridge.
  • a cartridge refill assembly be available to replace an empty inhaler cartridge.
  • a cartridge is provided in threaded engagement with an inhaler cap.
  • the inhaler cap is the same inhaler cap that is fitted over the nozzle.
  • the internal threads of the inhaler cap which correspond to the external threads on the nozzle must also correspond to the external threads on the cartridge .
  • the opening in the refill cartridge is initially sealed but is easily • " * punctured by tightly screwing the applicator with the spike onto to the refill cartridge.
  • the advantages of the present inhaler over known inhalers is that the inhalant retention means is accessible so that it can be properly saturated with inhalant from the cartridge. Moreover, the present inhaler provides three different means of applying inhalant: direct application with the cartridge; direct application with the applicator; and inhalation of the inhalant from the applicator through the nozzle .
  • the inhaler is also re-usable, that is, the cartridge can be replaced because it is sealed before first use. If the cartridge was not sealed, it would leak inhalant and be unsuitable for transportation and storage as a separate reusable component. Further, in use inhalant is not wasted through leakage because the spike on the underside of the applicator plugs the opening in the cartridge. In addition, the cartridge can hold different types of inhalant solution and the consumer need only to change the cartridge instead of the entire inhaler.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Packages (AREA)

Abstract

An inhaler (10) including: a cartridge (11) for storing inhalant, the cartridge having an opening (12) to dispense the inhalant; an inhalant retention means (14); and a nozzle (15); characterised in that an applicator (13) is detachably connected to the cartridge (11) and includes the inhalant retention means (14), and the nozzle is detachably connected to the applicator whereby removal of the nozzle (15) from the applicator exposes the retention means (14) which provides accessibility to saturate the retention means (14) with inhalant from the cartridge (11) and allows direct application of inhalant with the applicator (13), and wherein inhalant from the retention means (14) can be inhaled through the nozzle (15) when the nozzle (15) is connected to the applicator (13).

Description

AN INHALER
The present invention relates to an inhaler for inhaling and applying medicinal substances and the like.
BACKGROUND
Inhalers are used for the relief of nasal congestion or simply for refreshing inhalation. Medicated formulas are generally used as the inhaling substance, or inhalant, and primarily contain methanol and essential oils . A wick saturated with the inhalant is permanently enclosed within a dome-ended inhaler housing, or nozzle, and a variant of the inhaler is to mount the nozzle on a cartridge that is functionally separate from the nozzle. The cartridge serves only as a container to hold the inhalant .
The limitations associated with known inhalers such as those described above is that the wick is not always fully saturated resulting in inhalation of a progressively weaker inhalant. Also, since the wick is inaccessible for refilling, the entire inhaler has to be discarded once the wick dries up.
With the present invention it is intended to provide a means of directly applying the inhalant in a controlled manner and prolong the useful life of the inhaler. ~~ Further, the medication can be dabbed on or applied directly to give a stronger effect than through inhalation from the ozzle. This provides a convenient three-in-one application from a single device.
SUMMARY OF THE INVENTION
According to the present invention there is provided an inhaler including: a cartridge for storing inhalant, the cartridge having an opening to dispense the inhalant; an applicator detachably connected to the cartridge, the applicator including inhalant retention means ; and a nozzle detachably connected to the applicator; whereby removal of the nozzle from the applicator exposes the retention means which provides accessibility to saturate the retention means with inhalant from the cartridge and allows direct application of inhalant with the applicator, and wherein inhalant from the retention means can be inhaled through the nozzle when the nozzle is connected to the applicator.
The applicator can freely rotate on the cartridge to easily and correctly align the cartridge and applicator during manufacturing.
The retention means is preferably a sponge and more preferably, a sponge of cosmetic or medical grade.
The applicator is preferably attached to the cartridge at the opening.
Preferably, the opening in the cartridge is sealed prior to first use and is unsealed by means of a piercing spike on the applicator. The piercing spike also functions as a plug -for the opening once it is unsealed. "
Before first use it is preferable that an O-ring be disposed between the cartridge and applicator to separate the cartridge and applicator to prevent inadvertent piercing of the sealed opening.
Preferably, the nozzle is provided with apertures through which the inhalant is inhaled.
BRIEF DESCRIPTIONS OF THE DRAWINGS An embodiment, incorporating all aspects of the invention, will now be described by way of example only with reference to the accompanying drawings in which:
Figure 1 is a perspective view of a preferred embodiment of the invention;
Figure 2(a) is a sectional view along line A-A in figure 1 of a first arrangement of the invention illustrating the cartridge;
Figure 2(b) is a sectional view along ling A-A in figure 1 of a second arrangement of the invention illustrating the applicator in connection with the cartridge;
Figure 2(c) is a sectional view along line A-A in figure 1 of a third arrangement of the invention illustrating the nozzle in connection with the applicator and cartridge; and
Figure 3 is an exploded perspective view of the preferred embodiment of the invention.
DETAILED DESCRIPTION OF PREFERRED EMBODIMENT
The inhaler 10 of the present invention in its preferred embodiment is illustrated in figures 1 and 3 and includes a cylindrical cartridge 11 forming the base of the inhaler. The cartridge stores the inhaling substance, that is, the inhalant, which dispenses from the cartridge out of a regulated drip opening 12 located centrally at one end of the cartridge 11. An applicator 13 is screwed to the end of the cartridge having the opening and includes retention means 14 to retain inhalant . In the preferred embodiment the inhalant retention means is a sponge. The applicator can be used to directly apply inhalant to a surface in smaller and less concentrated quantities than direct application from the cartridge. A nozzle 15 is disposed over the sponge and detachably connects with the applicator. The applicator is also the source of inhalant vapours, that is, vapours from the sponge are inhaled through the nozzle. A cap 17 is adapted to cover the nozzle and provides the inhaler with a compact appearance. The entire inhaler, with the exception of the sponge, is made of plastics.
Figure 2(a) illustrates a first user arrangement of the inhaler wherein the cartridge 11 containing inhalant can be used for direct concentrated application of the inhalant. The end wall 20 of the cylindrical cartridge in which the central opening 12 is formed is made of a softer plastic than the rest of the cartridge. Prior to first use of the inhaler, the central opening in the soft plastic end wall is sealed with a thin piercable layer 21 of the soft plastic. To unseal the opening the plastic seal is punctured with a piercing spike 29 located on the underside of the applicator 13.
Figure 2(b) illustrates a second user arrangement wherein the applicator is used to directly apply inhalant by dabbing the inhalant saturated sponge on to a surface . The concentration of the inhalant applied with the applicator is less than application with the cartridge. The applicator 13 is screw fitted onto the cartridge at the end which has the opening 12. An external thread 22 at this end of the cartridge engages with an internal thread 23 on an annular skirt 2*4 of the applicator 13. At the other end of the annular skirt is a stepped section 25 defining an annular shoulder 26 and a reduced annular section 27 in coaxial alignment with the annular skirt 24. The upper end of the annular skirt is closed by the reduced annular section 27. The piercing spike 29 depends centrally from the reduced section 27 and points towards the central opening 12. Above the annular reduced section 27 is an upright hollow rectangular sponge holder 30 with an upper opening 31 in which to insert a sponge 14. Longitudinal ridges 32 along the interior walls of the sponge holder ensure the inserted sponge is gripped in place. The sponge preferably has a high liquid retention. The annular skirt, spike, reduced annular section and sponge holder are moulded as a single component.
To puncture the sealed opening 12 in the cartridge, the spike 29 moves downwardly towards the sealed opening as the applicator is screwed onto the cartridge. The length of the spike is such that when the applicator is fully screwed onto the cartridge the spike pierces the sealed layer and protrudes into the opening. Thereafter, inhalant can be dispensed from the cartridge through the opening and directly applied to tissues, skin or the like. Moreover, the inhalant is directly applied to and saturates the sponge on the applicator. To do this the applicator is first unscrewed and separated from the cartridge. Inhalant is dispensed from the cartridge by lightly tapping the cartridge. Since the whole upper part of the sponge is exposed and accessible, it is easy to saturate the sponge with inhalant . The upper part of the sponge is the most important in terms of close proximity to the nasal region during inhalation. The present inhaler ensures the upper part is fully saturated so as to deliver strong and effective vapours. Consequently, the inhaler has a longer useful life than conventional inhalers.
Once the sponge on the applicator has been saturated with inhalant the applicator is screwed back onto the cartridge with the spike then functioning as a plug for the opening to prevent leakage of the inhalant . There is thus no direct access of inhalant to the sponge through the applicator while the applicator and cartridge are connected. To prevent inadvertent piercing of the sealed opening prior to first use, an O-ring 35 is disposed between the applicator 13 and cartridge 11. The O-ring rests on a seat
36 on the cartridge circumventing the external thread 22. As the applicator is screwed onto the cartridge full engagement is not possible because the bottom annular edge
37 of the skirt of the applicator contacts the O-ring 35 and cannot be rotated on the external thread any further. Once the sealed opening in the cartridge has been pierced the O-ring no longer has any use and is discarded.
Figure 2(c) illustrates a third user arrangement wherein the nozzle 15 is fitted over the applicator 13 to provide a comfortable means for inhaling inhalant vapours . The nozzle has an annular flange 40 which forms a press fit with the annular shoulder 26 on the applicator 13. Projecting upwardly from the annual flange is a hollow cylindrical portion 41. The top end of the hollow portion 41 smoothly curves inwardly to partly close the upper end thereof but leaving a central circular aperture 16. Other circular apertures 16, in this embodiment four, are provided circumferentially on the wall of the hollow portion 41. In use, when the nozzle is fitted on the applicator, the sponge 14 and sponge holder 30 of the applicator extend upwardly into the hollow portion so that the nozzle encloses the sponge. The apertures 16 on the nozzle 15 allow vapour from the saturated sponge to beΛ inhaled through the nozzle.
An external screw thread 42 on the hollow portion and above the annual flange 40 engages with an internal thread (not shown) on the inhaler cap 17. The inhaler cap is simply a cylindrical wall closed at the non-threaded upper end.
In summary, the inhaler has three separate arrangements for administering the inhalant. Beginning with the full assembly as illustrated in figures 1 and 3, the cap is unscrewed and removed so the inhaler can be used as a regular nasal inhaler. The nozzle is further removed (for ease the nozzle is kept in engagement with the cap) exposing the saturated sponge which can be dabbed onto skin, etc and easily re-saturated. Lastly, the applicator is unscrewed from the cartridge (for ease the applicator is attached to the nozzle and cap assembly) thus exposing the regulated opening of the cartridge which can be used to directly dispense inhalant by lightly tapping the cartridge. The concentration of inhalant delivered from the cartridge is considerably higher than the inhalant applied with the applicator sponge.
The sponge is pre-soaked at the point of manufacture to ensure that vapour is available for inhalation upon first use. The sponge is kept saturated by repeatedly priming the sponge by dispensing inhalant from the cartridge.
It is intended that a cartridge refill assembly be available to replace an empty inhaler cartridge. Specifically, a cartridge is provided in threaded engagement with an inhaler cap. The inhaler cap is the same inhaler cap that is fitted over the nozzle. Thus, the internal threads of the inhaler cap which correspond to the external threads on the nozzle must also correspond to the external threads on the cartridge . The opening in the refill cartridge is initially sealed but is easily "* punctured by tightly screwing the applicator with the spike onto to the refill cartridge.
The advantages of the present inhaler over known inhalers is that the inhalant retention means is accessible so that it can be properly saturated with inhalant from the cartridge. Moreover, the present inhaler provides three different means of applying inhalant: direct application with the cartridge; direct application with the applicator; and inhalation of the inhalant from the applicator through the nozzle .
The inhaler is also re-usable, that is, the cartridge can be replaced because it is sealed before first use. If the cartridge was not sealed, it would leak inhalant and be unsuitable for transportation and storage as a separate reusable component. Further, in use inhalant is not wasted through leakage because the spike on the underside of the applicator plugs the opening in the cartridge. In addition, the cartridge can hold different types of inhalant solution and the consumer need only to change the cartridge instead of the entire inhaler.
It will be understood to persons skilled in the art of the invention that many modifications may be made without departing from the spirit and scope of the invention.

Claims

THE CLAIMS DEFINING THE INVENTION ARE AS FOLLOWS:
1. An inhaler (10) including: a cartridge (11) for storing inhalant, the cartridge having an opening (12) to dispense the inhalant; an inhalant retention means (14); and a nozzle (15) ; characterised in that an applicator (13) is detachably connected to the cartridge (11) and includes the inhalant retention means (14), and the nozzle is detachably connected to the applicator whereby removal of the nozzle (15) from the applicator exposes the retention means (14) which provides accessibility to saturate the retention means (14) with inhalant from the cartridge (11) and allows direct application of inhalant with the applicator (13), and wherein inhalant from the retention means (14) can be inhaled through the nozzle (15) when the nozzle (15) is connected to the applicator (13) .
2. The inhaler defined in claim 1 characterised in that the retention means (14) is a sponge mounted on an upper side of the applicator (13) .
3. The inhaler defined in any one of the preceding claims characterised in that the applicator (13) is screwed on to the cartridge (11) at the opening (12) .
4. The inhaler defined in any one of the preceding claims characterised in that the opening in the cartridge (11) has a seal (21) .
5. The inhaler defined in claim 4 characterised in that a downwardly directed spike (29) on an underside of the applicator (13) pierces the seal (21) when the applicator and cartridge are connected.
6. The inhaler defined in claim 5 characterised in that when the applicator (13) and cartridge (11) are connected during use the spike (29) inserts into the opening (12) and acts as a stopper.
7. The inhaler defined in claims 5 or 6 characterised in that a spacer (35) is disposed between the cartridge (11) and the applicator (13) before use to prevent inadvertent piercing of the seal (21) by the spike
(29).
8. The inhaler defined in any one of the preceding claims characterised in that the nozzle (15) is provided with a plurality of apertures (16) through which the inhalant is inhaled.
»
9. An inhaler defined in any one of the preceding claims characterised in that a cap (17) detachably connects to and covers the nozzle (15) .
10. An inhaler defined in any one of the preceding claims characterised in that the cartridge (11), applicator (13), nozzle (15) and cap (17) are moulded in plastics.
PCT/SG1999/000051 1999-04-30 1999-04-30 An inhaler WO2000066205A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PCT/SG1999/000051 WO2000066205A1 (en) 1999-04-30 1999-04-30 An inhaler
CN99816584.0A CN1367708A (en) 1999-04-30 1999-04-30 Inhaler
TW088114168A TW442305B (en) 1999-04-30 1999-08-19 An inhaler

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SG1999/000051 WO2000066205A1 (en) 1999-04-30 1999-04-30 An inhaler

Publications (1)

Publication Number Publication Date
WO2000066205A1 true WO2000066205A1 (en) 2000-11-09

Family

ID=20430213

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SG1999/000051 WO2000066205A1 (en) 1999-04-30 1999-04-30 An inhaler

Country Status (2)

Country Link
CN (1) CN1367708A (en)
WO (1) WO2000066205A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2419821A (en) * 2004-09-30 2006-05-10 Peter Bartingale Combined inhaler and applicator

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB537101A (en) * 1940-03-26 1941-06-09 Hermann Gadiel Improvements relating to medical inhaler devices
AU8718475A (en) * 1975-12-02 1977-06-09 Woodley G E Inhalers
WO1989001344A1 (en) * 1988-03-31 1989-02-23 Heinz Hermann Weick Device for evaporating active substances
DE3743680A1 (en) * 1987-12-23 1989-07-06 Spitzner Arzneimittelfabrik Gm Inhaler as pocket apparatus
FR2720281A1 (en) * 1994-05-26 1995-12-01 Karl Andre Leopold Penalba Medicinal liquid applicator

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB537101A (en) * 1940-03-26 1941-06-09 Hermann Gadiel Improvements relating to medical inhaler devices
AU8718475A (en) * 1975-12-02 1977-06-09 Woodley G E Inhalers
DE3743680A1 (en) * 1987-12-23 1989-07-06 Spitzner Arzneimittelfabrik Gm Inhaler as pocket apparatus
WO1989001344A1 (en) * 1988-03-31 1989-02-23 Heinz Hermann Weick Device for evaporating active substances
FR2720281A1 (en) * 1994-05-26 1995-12-01 Karl Andre Leopold Penalba Medicinal liquid applicator

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2419821A (en) * 2004-09-30 2006-05-10 Peter Bartingale Combined inhaler and applicator
GB2419821B (en) * 2004-09-30 2008-08-06 Peter Bartingale Improvements to fragrance inhalers and applicators

Also Published As

Publication number Publication date
CN1367708A (en) 2002-09-04

Similar Documents

Publication Publication Date Title
CA2011734C (en) Liquid droplet dispensing apparatus
US6053363A (en) Packaging and dispensing assembly for a cosmetic, pharmaceutical or dermo-pharmaceutical product
RU2675657C1 (en) System and device for filling tank with liquid
US8408427B2 (en) Single dose nasal spray pump
US4605398A (en) Dispensing device for container having fluid to be controllably dispensed into an eye
US20170135398A1 (en) Dispenser
US20200078540A1 (en) Liquid dispensing and methods for dispensing liquids
SK286702B6 (en) Cartridge for a liquid, its use and dispensing device
US20130092709A1 (en) Medicament dispensing device
US20040097890A1 (en) Applicator for scalp medicine
WO2000066205A1 (en) An inhaler
JPS6132700Y2 (en)
US20210187212A1 (en) Inhaler and method
US20120193377A1 (en) Nasal spray pump
US20080247809A1 (en) Assembly With Applicator Device For Applying A Liquid Such As Scent On A Wetable Surface Such As Human Skin
JPH0441983Y2 (en)
TW442305B (en) An inhaler
US10753780B2 (en) Liquid disperser
JPH0578237U (en) Pharmaceutical container
US20210252235A1 (en) Prescription bottle cap capable of administering opioid overdose reversal agent
GB2304644A (en) Ball type perfume applicator
WO2008098860A1 (en) Container for a medical device
JPH0446736Y2 (en)
EP2986268B1 (en) Liquid dispensing
PH26430A (en) Liquid droplet dispensing apparatus

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 99816584.0

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): CN ID SG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)